ArticleBMC cancer2024

A multicentric, single arm, open-label, phase I/II study evaluating PSMA targeted radionuclide therapy in adult patients with metastatic clear cell renal cancer (PRadR).

David Kryza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.